How often do patients develop endometriosis following laparoscopic supracervical hysterectomy with uterine morcellation? To better understand the resulting rates of endometriosis via laparoscopic versus transvaginal or abdominal hysterectomies, researchers conducted a single center case-control study.
How often do patients develop endometriosis following laparoscopic supracervical hysterectomy with uterine morcellation? To better understand the resulting rates of endometriosis via laparoscopic versus transvaginal or abdominal hysterectomies, researchers conducted a single center case-control study. Their findings, which were originally presented at the Society of Gynecologic Surgeons’ 37th Annual Meeting, can be found in the March issue of The Journal of Minimally Invasive Gynecology.
In this case-control study, Dr. Mitchell W. Schuster, surgeon with OB-GYN Associates in Decatur, Alabama, and colleagues compared women who had received laparoscopic supracervical hysterectomies with morcellation (cases; N=277) with women who had transvaginal or abdominal hysterectomies without morcellation (controls; N=187). The procedures were performed from January 2006 through December 2008. In the study, operative procedures for other benign indications were repeated in 3.5% of the patients who had prior hysterectomy.
Schuster et al. found 102 patients with endometriosis at the time of hysterectomy; diagnosis was made via pathologic evaluation or gross visualization. Repeat operative procedures were performed for pain and bleeding in 3.3% of the women without endometriosis. While Schuster and colleagues found newly diagnosed endometriosis in 63% of patients who underwent laparoscopic supracervical surgery, they found that only 28.6% of patients who received transvaginal or abdominal surgery received such a diagnosis. Based on these data, however, the researchers noted the same rate across the groups; both case and control groups had a rate of 1.4% of newly diagnosed endometriosis.
Furthermore, Schuster and colleagues found that repeat operative procedures for pain or bleeding were performed in 2.9% of the patients. All of these patients were from the case group (i.e., received laparoscopic supracervical hysterectomies with morcellation). Schuster et al. noted two out of the three of these women who received a second surgery had recurrent/continued endometriosis.
“Newly diagnosed endometriosis was noted in 1.4% of patients after hysterectomy, with a similar incidence between the LSH [laparoscopic supracervical hysterectomies] and control groups,” the authors concluded. “Reoperation for those with endometriosis at the time of LSH with morcellation was infrequent, but endometriosis was usually found. Further research is needed to delineate risk factors for development of de novo endometriosis after hysterectomy.”
Reference:
MW, Wheeler TL II, Richter HE. Endometriosis after laparoscopic supracervical hysterectomy with uterine morcellation: a case control study. J Minim Invasive Gynecol. 2012;19(2):183-7.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
PCOS and irregular cycles tied to cardiometabolic risks
May 15th 2024A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More